Home › Funds › Morgan Stanley › DNLI
Morgan Stanley position in DNLI
DENALI THERAPEUTICS INC · Health Care
Latest position (Q2 2026)961.05K sh
Reported value held$24.72M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 383.99K | $19.37M | New |
| Q4 2021 | 287.26K | $12.81M | Reduce |
| Q1 2022 | 705.65K | $22.70M | Add |
| Q2 2022 | 423.01K | $12.45M | Reduce |
| Q3 2022 | 681.33K | $20.91M | Add |
| Q4 2022 | 432.49K | $12.03M | Reduce |
| Q1 2023 | 569.12K | $13.11M | Add |
| Q2 2023 | 1.08M | $31.78M | Add |
| Q3 2023 | 981.57K | $20.25M | Reduce |
| Q4 2023 | 977.49K | $20.98M | Hold |
| Q1 2024 | 928.13K | $19.05M | Reduce |
| Q2 2024 | 1.22M | $28.42M | Add |
| Q3 2024 | 1.74M | $50.82M | Add |
| Q4 2024 | 1.23M | $25.05M | Reduce |
| Q1 2025 | 1.25M | $17.04M | Add |
| Q2 2025 | 1.31M | $18.36M | Add |
| Q3 2025 | 1.69M | $24.53M | Add |
| Q4 2025 | 1.22M | $20.14M | Reduce |
| Q1 2026 | 1.10M | $21.21M | Reduce |
| Q2 2026 | 961.05K | $24.72M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding DNLI
- BlackRock Inc 14.03M sh · $360.76M · Q2 2026
- Baillie Gifford & Co 11.96M sh · $307.62M · Q2 2026
- Vanguard Group 13.06M sh · $215.59M · Q4 2025
- Temasek Holdings 7.01M sh · $180.37M · Q2 2026
- Fidelity Management & Research (FMR) 4.54M sh · $116.66M · Q2 2026
- Goldman Sachs Group 4.16M sh · $106.89M · Q2 2026
- Geode Capital Management 3.97M sh · $102.21M · Q2 2026
- UBS Group AG 3.12M sh · $80.26M · Q2 2026
- Norges Bank Investment Management 2.82M sh · $72.65M · Q2 2026
- Capital Research Global Investors 2.57M sh · $65.99M · Q2 2026
- Casdin Capital 2.04M sh · $52.60M · Q2 2026
- Principal Global Investors 1.42M sh · $36.52M · Q2 2026